Unified global commercialization platform partnering with biotech companies to bring breakthrough therapies—especially for severe and rare diseases—to patients worldwide. Affiliate-like model that integrates commercial, medical, and operational capabilities to accelerate access and expand reach beyond the U.S., Western Europe, and Japan while preserving local impact.